Solution to platelet 'puzzle' uncovers blood disorder link

April 7, 2014
Dr. Ashley Ng and colleagues from the Walter and Eliza Hall Institute in Melbourne, Australia, have solved a puzzle about how blood-making hormones stimulate the bone marrow to make platelets. Credit: Walter and Eliza Hall Institute of Medical Research

Melbourne researchers have solved a puzzle as to how an essential blood-making hormone stimulates production of the blood clotting cells known as platelets.

Platelets are essential for stopping bleeding and are produced by small fragments breaking off their 'parent' cells, called megakaryocytes.

The discovery, made by scientists at the Walter and Eliza Hall Institute, identified how cells could become overstimulated and produce too many . In blood diseases such as essential thrombocythemia, too many platelets can lead to clogging of the blood vessels, causing clots, heart attack or strokes.

Institute researchers Dr Ashley Ng, Dr Maria Kauppi, Professor Warren Alexander, Professor Don Metcalf and colleagues led the research, published today in the journal Proceedings of the National Academy of Sciences.

Dr Ng said the hormone thrombopoietin was responsible for signalling to produce platelets but, until now, researchers did not know precisely which cells responded to its signals. By studying the receptor for thrombopoietin, called Mpl, on in the bone marrow, the team pinpointed the cells involved in making platelets after thrombopoietin stimulation, and made an unexpected discovery.

"Thrombopoietin did not directly stimulate the platelet's 'parent' cells, the megakaryocytes, to make more platelets," Dr Ng said. "Thrombopoietin signals actually acted on stem cells and progenitor cells, several generations back."

To reach this conclusion, the researchers genetically removed the Mpl receptors from megakaryocytes and platelets. Dr Ng said the result was very surprising. "The progenitor and in the bone marrow began massively expanding and effectively turned the bone marrow into a megakaryocyte-making machine," Dr Ng said.

"Our findings support a theory whereby megakaryocytes and platelets control platelet numbers by 'mopping up' excess amounts of thrombopoietin in the bone marrow. In fact, we show this 'mopping up' action is absolutely essential in preventing blood disease where too many megakaryocytes and platelets are produced."

The findings may have implications for human disease, Dr Ng said. "We know people with myeloproliferative disorders, such as essential thrombocythemia, produce too many megakaryocytes and platelets," he said.

"Interestingly, previous studies have shown megakaryocytes and platelets in people with essential thrombocythemia have fewer Mpl receptors, which fits our model for excessive . By using genetic 'signatures',we were able to compare the blood progenitor cells responsible for overproducing in our model, to progenitor cells in people with essential thrombocythemia. We were able to show that in our model and in patients with essential thrombocythemia, had a signature of excessive thrombopoietin stimulation.

"We think this study now provides a comprehensive model of how thrombopoietin controls platelet production, and perhaps gives some insight into the biology and mechanism behind specific myeloproliferative disorders," Dr Ng said.

Explore further: Surprise finding redraws 'map' of blood cell production

More information: Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1404354111

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.